Hepacyl Therapeutics Overview

  • Founded
  • 2010
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Hepacyl Therapeutics General Information


Provider of therapeutic services for immune system. The company's therapeutic services engage in drug discovery and development services for the treatment of Cancer, HIV/Aids, Malaria and Tuberculosis by developing molecules that safely induce specific response of our immune system to both pathogens and abnormal situations, enabling healthcare providers to treat conditions such as cancer and autoimmune diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Calle Duque de la Victoria, 13, 4°A
  • 47001 Valladolid
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hepacyl Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2016 00.00 Completed Out of Business
2. Early Stage VC (Series A) 00.00 00.00 Completed Startup
1. Platform Creation 01-May-2010 Completed Startup
To view Hepacyl Therapeutics’s complete valuation and funding history, request access »

Hepacyl Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Ignacio de la Rica Chief Executive Officer & Chairman
You’re viewing 1 of 2 executive team members. Get the full list »

Hepacyl Therapeutics Board Members (1)

Name Representing Role Since
Ignacio de la Rica Hepacyl Therapeutics Chief Executive Officer & Chairman 000 0000
To view Hepacyl Therapeutics’s complete board members history, request access »